Stefano Colloca

Stefano Colloca

UNVERIFIED PROFILE

Are you Stefano Colloca?   Register this Author

Register author
Stefano Colloca

Stefano Colloca

Publications by authors named "Stefano Colloca"

Are you Stefano Colloca?   Register this Author

53Publications

2336Reads

28Profile Views

Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix.

J Immunother 2017 Feb/Mar;40(2):51-61

*Department of International Health, Immunology and Microbiology, Centre for Medical Parasitology, Copenhagen ‡Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark †Primate Research Center, Bogor Agricultural University, PSSP-IPB, Bogor, Indonesia Departments of §Pediatrics ∥Obstetrics, Gynecology and Women's Health ¶Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY #ReiThera, viale Citta' d'Europa, Rome, Italy **KEIRES, Bäumleingasse, Basel, Switzerland ††CEINGE, Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000153DOI Listing
January 2018

Chimpanzee Adenovirus Vector Ebola Vaccine.

N Engl J Med 2017 03 26;376(10):928-938. Epub 2014 Nov 26.

From the Vaccine Research Center (J.E.L., A.D.D., D.A.S., E.E.C., L.N., M.E.E., N.M.B., A.P., S.S., I.J.G., S.A.P., L.A.H., C.S.H., G.Y., R.T.B., R.M.S., M.R., J.R.M., R.A.K., N.J.S., B.S.G.) and the Biostatistics Research Branch, Division of Clinical Research (Z.H., G.J.), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; GlaxoSmithKline Vaccines, Rixensart, Belgium (F.R.); ReiThera, Rome (A.N., S.C.), and CEINGE and the Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples (A.N.) - both in Italy; and Keires, Basel, Switzerland (R.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1410863DOI Listing
March 2017

Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.

Vaccine 2016 10 12;34(44):5344-5351. Epub 2016 Sep 12.

Center for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2016.08.089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330181PMC
October 2016

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

N Engl J Med 2016 Apr 28;374(17):1635-46. Epub 2015 Jan 28.

From the Jenner Institute and Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford (K.E., T.R., N.V., G.B., D.W., T.L., E.B.I., R.P., C.M.T., N.J.E., G.L., J.J., M.G., A.M., M.W., I.P., N.L., R.R., F.H., C.B., K.S.-D., J.P., E.B., A.J.P., S.J.D., A.L., S.C.G., A.V.S.H.), and Viral Pseudotype Unit, Faculty of Science and Technology, University of Westminster (E.M.B., E.W.), and Virus Reference Department, Public Health Agency (D.S., R.T.), London - all in the United Kingdom; the Institute of Virology, Philipps University Marburg (S.K.F., T.S., N.B., V.K., S.B.), and German Center for Infection Research, Partner Site Giessen-Marburg-Langen (S.B.), Marburg, and Bavarian Nordic, Martinsried (A.V., P.C.) - all in Germany; GlaxoSmithKline Biologicals, Rixensart, Belgium (F.R., I.D.R., W.R.B.); ReiThera, Rome (A.N., L.S., S.C., A.F., S.D.M.), and CEINGE and the Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples (A.N.) - both in Italy; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda (N.J.S., D.A.S., O.T.M., J.E.L., R.M.S., B.S.G., R.A.K.), and the Center for Vaccine Development, University of Maryland School of Medicine, Baltimore (M.M.L.) - both in Maryland; and Keires, Basel, Switzerland (R.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1411627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798586PMC
April 2016

Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.

Vaccine 2015 Dec 26;33(51):7344-7351. Epub 2015 Oct 26.

Vaccine Research Center, NIAID, National Institutes of Health, Bldg. 40, Room 4502, MSC-3005, 40 Convent Drive, Bethesda, MD 20892-3005, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2015.10.023DOI Listing
December 2015

Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.

Mol Ther 2014 Feb 31;22(2):464-475. Epub 2013 Oct 31.

The Jenner Institute Laboratories, University of Oxford, Old Road Campus Research Building, Oxford, UK; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, The John Radcliffe, Oxford, UK; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, UK; Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2013.248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911893PMC
February 2014

Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.

PLoS One 2013 11;8(3):e55435. Epub 2013 Mar 11.

Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration,Bethesda, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0055435PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594242PMC
December 2013